{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:36:31Z","timestamp":1788798991263,"version":"build-2803163510"},"reference-count":47,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The mammalian sirtuins (SIRTs), consisting of seven members (SIRT 1\u20137), are NAD+-dependent histone deacetylases (HDACs). Similar to other classical NAD+-independent HDACs, SIRTs regulate a wide range of key biological processes by deacetylating both histone and non-histone proteins. By linking cellular metabolism to tissue homeostasis, SIRTs play important roles in physiological regulation and are often deregulated in many human diseases including diabetes, neurodegeneration and cancer, particularly sarcomas. Here, we reviewed the expression and roles of SIRTs, especially the most studied family member SIRT 1, across several types of human sarcomas, including both bone and soft tissues sarcomas. We also discussed the clinical relevance of SIRTs and the potential of their modulation as a therapeutic strategy in sarcomas.<\/jats:p>","DOI":"10.3390\/ijms27136042","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:43:14Z","timestamp":1783345394000},"page":"6042","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The SIRT Family: Subcellular Localization and Main Functions"],"prefix":"10.3390","volume":"27","author":[{"given":"Ping","family":"Quan","sequence":"first","affiliation":[{"name":"Independent Researcher, 8605 Kapfenberg, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8017-3400","authenticated-orcid":false,"given":"Christoph","family":"Schatz","sequence":"additional","affiliation":[{"name":"Tyrolpath Obrist Brunhuber GmbH, Hauptplatz 4, 6511 Zams, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria Maria","family":"Filippini","sequence":"additional","affiliation":[{"name":"Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Haybaeck","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Salzkammergut-Klinikum V\u00f6cklabruck, 4840 V\u00f6cklabruck, Austria"},{"name":"Institute of Pathology, Medical University of Maribor, SI-2000 Maribor, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-022-01257-8","article-title":"The Sirtuin Family in Health and Disease","volume":"7","author":"Wu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_2","first-page":"1399","article-title":"The Emerging and Diverse Roles of Sirtuins in Cancer: A Clinical Perspective","volume":"6","author":"Yuan","year":"2013","journal-title":"OncoTargets Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/gb-2004-5-5-224","article-title":"Sirtuins: Sir2-Related NAD-Dependent Protein Deacetylases","volume":"5","author":"North","year":"2004","journal-title":"Genome Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1152\/physrev.00022.2011","article-title":"Sirtuin 1 and Sirtuin 3: Physiological Modulators of Metabolism","volume":"92","author":"Nogueiras","year":"2012","journal-title":"Physiol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.humpath.2012.10.001","article-title":"Sirtuin 1 (SIRT1): A Potential Immunohistochemical Marker and Therapeutic Target in Soft Tissue Neoplasms with Myoid Differentiation","volume":"44","author":"Dickson","year":"2013","journal-title":"Hum. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Berclaz, L.M., Altendorf-Hofmann, A., D\u00fcrr, H.R., Klein, A., Angele, M.K., Albertsmeier, M., Schmidt-Hegemann, N.-S., Di Gioia, D., Kn\u00f6sel, T., and Lindner, L.H. (2021). Expression Patterns of TOP2A and SIRT1 Are Predictive of Survival in Patients with High-Risk Soft Tissue Sarcomas Treated with a Neoadjuvant Anthracycline-Based Chemotherapy. Cancers, 13.","DOI":"10.3390\/cancers13194877"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kim, J.R., Moon, Y.J., Kwon, K.S., Bae, J.S., Wagle, S., Yu, T.K., Kim, K.M., Park, H.S., Lee, J.-H., and Moon, W.S. (2013). Expression of SIRT1 and DBC1 Is Associated with Poor Prognosis of Soft Tissue Sarcomas. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0074738"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"300060520926355","DOI":"10.1177\/0300060520926355","article-title":"Association of Sirtuin-1 and Vascular Endothelial Growth Factor Expression with Tumor Progression and Poor Prognosis in Liposarcoma","volume":"48","author":"Wu","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.21873\/anticanres.13223","article-title":"SIRT1 Expression Is Associated With Cell Proliferation in Angiosarcoma","volume":"39","author":"Chosokabe","year":"2019","journal-title":"Anticancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"9841","DOI":"10.1038\/srep09841","article-title":"SIRT7 Inactivation Reverses Metastatic Phenotypes in Epithelial and Mesenchymal Tumors","volume":"5","author":"Malik","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nature11043","article-title":"SIRT7 Links H3K18 Deacetylation to Maintenance of Oncogenic Transformation","volume":"487","author":"Barber","year":"2012","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejphar.2009.03.004","article-title":"Resveratrol Inhibits Proliferation and Promotes Apoptosis of Osteosarcoma Cells","volume":"609","author":"Li","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/bjc.2017.174","article-title":"Post-Translational Regulation Contributes to the Loss of LKB1 Expression through SIRT1 Deacetylase in Osteosarcomas","volume":"117","author":"Presneau","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"79654","DOI":"10.18632\/oncotarget.12916","article-title":"SIRT1 Promotes Metastasis of Human Osteosarcoma Cells","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.prp.2016.02.002","article-title":"Expression of Leptin and Sirtuin-1 Is Associated with Poor Prognosis in Patients with Osteosarcoma","volume":"212","author":"Feng","year":"2016","journal-title":"Pathol. Res. Pract."},{"key":"ref_16","first-page":"3517","article-title":"MiR-654-5p Regulated Cell Progression and Tumor Growth through Targeting SIRT6 in Osteosarcoma","volume":"24","author":"Xu","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s13046-020-01759-9","article-title":"Inhibition of SIRT6 Potentiates the Anti-Tumor Effect of Doxorubicin through Suppression of the DNA Damage Repair Pathway in Osteosarcoma","volume":"39","author":"Zhang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_18","first-page":"1237","article-title":"SIRT6 Inhibits Proliferation and Invasion in Osteosarcoma Cells by Targeting N-Cadherin","volume":"17","author":"Gao","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_19","first-page":"1788","article-title":"Sirtuin 7 Plays an Oncogenic Role in Human Osteosarcoma via Downregulating CDC4 Expression","volume":"7","author":"Wei","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.biopha.2018.04.148","article-title":"MicroRNA-340 Inhibits the Growth and Invasion of Angiosarcoma Cells by Targeting SIRT7","volume":"103","author":"Wang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e1483","DOI":"10.1038\/cddis.2014.385","article-title":"SIRT1 and SIRT2 Inhibition Impairs Pediatric Soft Tissue Sarcoma Growth","volume":"5","author":"Ma","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/09674845.2017.1340225","article-title":"Elevated Levels of Serum MiR-152 and miR-24 in Uterine Sarcoma: Potential for Inducing Autophagy via SIRT1 and Deacetylated LC3","volume":"75","author":"Tong","year":"2018","journal-title":"Br. J. Biomed. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"41203","DOI":"10.1038\/srep41203","article-title":"The Expression of SIRT1 Regulates the Metastaticplasticity of Chondrosarcoma Cells by Inducing Epithelial-Mesenchymal Transition","volume":"7","author":"Feng","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"101342","DOI":"10.1016\/j.xcrm.2023.101342","article-title":"Decoupling NAD+ Metabolic Dependency in Chondrosarcoma by Targeting the SIRT1-HIF-2\u03b1 Axis","volume":"5","author":"Suh","year":"2024","journal-title":"Cell Rep. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1038\/s41467-019-12525-7","article-title":"Integrated Molecular Characterization of Chondrosarcoma Reveals Critical Determinants of Disease Progression","volume":"10","author":"Nicolle","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1038\/s41598-017-03635-7","article-title":"Induction of Sirtuin-1 Signaling by Resveratrol Induces Human Chondrosarcoma Cell Apoptosis and Exhibits Antitumor Activity","volume":"7","author":"Chao","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.3892\/mmr.2016.5554","article-title":"Resveratrol Inhibits Phosphorylation within the Signal Transduction and Activator of Transcription 3 Signaling Pathway by Activating Sirtuin 1 in SW1353 Chondrosarcoma Cells","volume":"14","author":"Jin","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_28","first-page":"1643","article-title":"TRIM2 Regulates the Development and Metastasis of Tumorous Cells of Osteosarcoma","volume":"53","author":"Qin","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.1158\/0008-5472.CAN-14-1736","article-title":"Suppression of Deacetylase SIRT1 Mediates Tumor-Suppressive NOTCH Response and Offers a Novel Treatment Option in Metastatic Ewing Sarcoma","volume":"74","author":"Ban","year":"2014","journal-title":"Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Kiss, A., Csikos, C., Regdon, Z., Polg\u00e1r, Z., Vir\u00e1g, L., and Heged\u0171s, C. (2021). NMNAT1 Is a Survival Factor in Actinomycin D-Induced Osteosarcoma Cell Death. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168869"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"10183","DOI":"10.1158\/0008-5472.CAN-05-2002","article-title":"Control of Multidrug Resistance Gene Mdr1 and Cancer Resistance to Chemotherapy by the Longevity Gene SIRT1","volume":"65","author":"Chu","year":"2005","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1080\/21691401.2019.1648280","article-title":"SIRT1 Modulates H3 Phosphorylation and Facilitates Osteosarcoma Cell Autophagy","volume":"47","author":"Ying","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/s41419-022-05388-2","article-title":"SIRT2 Promotes the Viability, Invasion and Metastasis of Osteosarcoma Cells by Inhibiting the Degradation of Snail","volume":"13","author":"Tian","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.yexcr.2014.11.001","article-title":"Sirtuin 7 Promotes Cellular Survival Following Genomic Stress by Attenuation of DNA Damage, SAPK Activation and P53 Response","volume":"331","author":"Kiran","year":"2015","journal-title":"Exp. Cell Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"11242","DOI":"10.1074\/jbc.AC118.003325","article-title":"The Epigenetic Regulator SIRT7 Guards against Mammalian Cellular Senescence Induced by Ribosomal DNA Instability","volume":"293","author":"Paredes","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.bbrc.2017.11.164","article-title":"Extracellular Vesicle-Encapsulated microRNA-761 Enhances Pazopanib Resistance in Synovial Sarcoma","volume":"495","author":"Shiozawa","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1002\/jcb.27653","article-title":"SIRT1-ZEB1-Positive Feedback Promotes Epithelial-Mesenchymal Transition Process and Metastasis of Osteosarcoma","volume":"120","author":"Yu","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1080\/14728222.2023.2263908","article-title":"A1BG-AS1 Promotes the Biological Functions of Osteosarcoma Cells via Regulating the microRNA-148a-3p\/USP22 Axis and Stabilizing the Expression of SIRT1 through Deubiquitinase Function","volume":"27","author":"Han","year":"2023","journal-title":"Expert. Opin. Ther. Targets"},{"key":"ref_39","first-page":"264","article-title":"MiR-217 Inhibits Proliferation, Migration, and Invasion by Targeting SIRT1 in Osteosarcoma","volume":"34","author":"He","year":"2019","journal-title":"Cancer Biother. Radiopharm."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.gene.2012.01.042","article-title":"SIRT3 Gene Expression: A Link between Inherited Mitochondrial DNA Variants and Oxidative Stress","volume":"497","author":"Rose","year":"2012","journal-title":"Gene"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ncomms1001","article-title":"SIRT 1 Improves Healthy Ageing and Protects from Metabolic Syndrome-Associated Cancer","volume":"1","author":"Herranz","year":"2010","journal-title":"Nat. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00432-015-1994-2","article-title":"Reverse Chemomodulatory Effects of the SIRT1 Activators Resveratrol and SRT1720 in Ewing\u2019s Sarcoma Cells: Resveratrol Suppresses and SRT1720 Enhances Etoposide- and Vincristine-Induced Anticancer Activity","volume":"142","author":"Sonnemann","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s10637-017-0541-1","article-title":"The Sirtuin 1\/2 Inhibitor Tenovin-1 Induces a Nonlinear Apoptosis-Inducing Factor-Dependent Cell Death in a P53 Null Ewing\u2019s Sarcoma Cell Line","volume":"36","author":"Marx","year":"2018","journal-title":"Investig. New Drugs"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejphar.2013.05.017","article-title":"SIRT1 Inhibition by Melatonin Exerts Antitumor Activity in Human Osteosarcoma Cells","volume":"715","author":"Cheng","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"ref_45","first-page":"73","article-title":"2-Methoxyestradiol Affects Mitochondrial Biogenesis Pathway and Succinate Dehydrogenase Complex Flavoprotein Subunit A in Osteosarcoma Cancer Cells","volume":"15","author":"Eisler","year":"2017","journal-title":"Cancer Genom. Proteom."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ccr.2008.03.004","article-title":"Discovery, in Vivo Activity, and Mechanism of Action of a Small-Molecule P53 Activator","volume":"13","author":"Lain","year":"2008","journal-title":"Cancer Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"106693","DOI":"10.1016\/j.phrs.2023.106693","article-title":"Novel Therapeutic Strategies Targeting UCP2 in Uterine Leiomyosarcoma","volume":"189","author":"Nagao","year":"2023","journal-title":"Pharmacol. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/13\/6042\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:00:29Z","timestamp":1783346429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/13\/6042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":47,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ijms27136042"],"URL":"https:\/\/doi.org\/10.3390\/ijms27136042","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]}}}